Study | Exclusion reasons | Rmk | Reference |
---|---|---|---|
He (Topiramate) (Controls exposed to Lamotrigine, sick), 2017 | repeat population groups, duplicate reports (most recent study included) | Overlapping: He 2017 totally included in Li 2023, with a longer study period and more pregnancies => Use of Li 2023. Patients who developed epilepsy during pregnancy or after delivery were not included. |
He Epilepsy Behav 2017; 74:10-14 10.1016/j.yebeh.2017.05.034 |
He (Topiramate) (Controls unexposed, sick), 2017 | repeat population groups, duplicate reports (most recent study included) | Overlapping: He 2017 totally included in Li 2023, with a longer study period and more pregnancies => Use of Li 2023. Patients who developed epilepsy during pregnancy or after delivery were not included. |
He Epilepsy Behav 2017; 74:10-14 10.1016/j.yebeh.2017.05.034 |